BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 29088977)

  • 1. A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology.
    Maurea N; Spallarossa P; Cadeddu C; Madonna R; Mele D; Monte I; Novo G; Pagliaro P; Pepe A; Tocchetti CG; Zito C; Mercuro G
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1(Suppl 1):S93-S104. PubMed ID: 27183530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review and meta-analysis of beta-blockers and renin-angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer.
    Lewinter C; Nielsen TH; Edfors LR; Linde C; Bland JM; LeWinter M; Cleland JGF; Køber L; Braunschweig F; Mansson-Broberg A
    Eur Heart J; 2022 Jul; 43(27):2562-2569. PubMed ID: 34951629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-angiotensin-aldosterone system blockers for heart failure with reduced ejection fraction or left ventricular dysfunction: Network meta-analysis.
    Xie W; Zheng F; Song X; Zhong B; Yan L
    Int J Cardiol; 2016 Feb; 205():65-71. PubMed ID: 26720043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE inhibitors and beta blockers in chronic congestive cardiac failure: therapeutic basis.
    Manoria PC; Manoria P
    J Indian Med Assoc; 2003 May; 101(5):311-2, 315. PubMed ID: 14575221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis.
    Raimondi S; Botteri E; Munzone E; Cipolla C; Rotmensz N; DeCensi A; Gandini S
    Int J Cancer; 2016 Jul; 139(1):212-9. PubMed ID: 26916107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on left ventricular mass index and ejection fraction in hemodialysis patients: A meta-analysis with trial sequential analysis of randomized controlled trials.
    Yang Y; Wang R; Li MX; Xing Y; Li WG
    Int J Cardiol; 2016 Sep; 219():350-7. PubMed ID: 27352206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic measures in the prevention of left ventricular dysfunction associated with molecular-targeted therapies in the treatment of cancer patients.
    Awada G; de Azambuja E; Awada A
    Expert Opin Drug Metab Toxicol; 2017 Dec; 13(12):1205-1215. PubMed ID: 29088977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic therapies across the continuum of left ventricular dysfunction.
    Abraham WT; Greenberg BH; Yancy CW
    Am J Cardiol; 2008 Sep; 102(5A):21G-28G. PubMed ID: 18722188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthracycline-related cardiotoxicity in childhood cancer survivors.
    Lipshultz SE; Karnik R; Sambatakos P; Franco VI; Ross SW; Miller TL
    Curr Opin Cardiol; 2014 Jan; 29(1):103-12. PubMed ID: 24284979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardioprotective treatment during adjuvant cancer therapy].
    Gulati G; Heck SL; Ree AH; Gravdehaug B; Røsjø H; Steine K; Bratland Å; Hoffmann P; Geisler J; Omland T
    Tidsskr Nor Laegeforen; 2013 Sep; 133(17):1832-6. PubMed ID: 24042297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of heart failure.
    Cohn JN
    Cardiology; 1999; 92 Suppl 1():22-5; discussion 26-8. PubMed ID: 10652968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world algorithms for the optimal use of drugs and devices in the patient post myocardial infarction and the future of post myocardial infarction management.
    Rudo TJ; Kowey PR
    Clin Cardiol; 2005 Nov; 28(11 Suppl 1):I58-63. PubMed ID: 16450814
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.